1.86
price down icon1.59%   -0.03
pre-market  Pre-market:  1.88   0.02   +1.08%
loading
Cronos Group Inc stock is traded at $1.86, with a volume of 1.15M. It is down -1.59% in the last 24 hours and down -7.00% over the past month. Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
See More
Previous Close:
$1.89
Open:
$1.87
24h Volume:
1.15M
Relative Volume:
0.75
Market Cap:
$711.51M
Revenue:
$87.89M
Net Income/Loss:
$-73.96M
P/E Ratio:
-10.09
EPS:
-0.1843
Net Cash Flow:
$-46.26M
1W Performance:
-7.46%
1M Performance:
-7.00%
6M Performance:
-14.68%
1Y Performance:
-7.92%
1-Day Range:
Value
$1.86
$1.90
1-Week Range:
Value
$1.86
$2.03
52-Week Range:
Value
$1.83
$3.14

Cronos Group Inc Stock (CRON) Company Profile

Name
Name
Cronos Group Inc
Name
Phone
(416) 504-0004
Name
Address
4491 CONCESSION RD 12, STAYNER, ON
Name
Employee
459
Name
Twitter
@cronosgroup
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
CRON's Discussions on Twitter

Compare CRON with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CRON
Cronos Group Inc
1.86 711.51M 87.89M -73.96M -46.26M -0.1843
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
160.06 71.67B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 47.44B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.19 46.08B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.46 18.86B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.36 13.97B 612.78M -86.37M -62.91M -0.87

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-02-22 Initiated Bernstein Mkt Perform
Jul-28-22 Upgrade Canaccord Genuity Hold → Buy
May-11-22 Upgrade CIBC Neutral → Sector Outperform
Mar-22-22 Upgrade Barclays Underweight → Equal Weight
Jan-27-22 Upgrade Jefferies Underperform → Hold
Nov-18-21 Resumed BofA Securities Underperform
Apr-28-21 Resumed BofA Securities Underperform
Feb-22-21 Downgrade CIBC Sector Outperform → Neutral
Jun-24-20 Upgrade Raymond James Mkt Perform → Outperform
Apr-27-20 Downgrade Raymond James Outperform → Mkt Perform
Apr-14-20 Downgrade Piper Sandler Overweight → Neutral
Apr-02-20 Downgrade BofA/Merrill Buy → Neutral
Mar-31-20 Downgrade Canaccord Genuity Hold → Sell
Mar-04-20 Upgrade MKM Partners Neutral → Buy
Mar-03-20 Downgrade Stifel Buy → Hold
Oct-18-19 Upgrade Stifel Hold → Buy
Sep-20-19 Initiated MKM Partners Neutral
Sep-05-19 Upgrade BMO Capital Markets Underperform → Market Perform
Aug-13-19 Initiated Piper Jaffray Overweight
Aug-09-19 Upgrade Canaccord Genuity Sell → Hold
Jun-28-19 Initiated Consumer Edge Research Equal Weight
Jun-06-19 Initiated Stifel Hold
Jun-05-19 Upgrade BofA/Merrill Underperform → Buy
Apr-17-19 Initiated BofA/Merrill Underperform
Mar-27-19 Downgrade Canaccord Genuity Hold → Sell
Feb-25-19 Initiated Jefferies Underperform
Jan-18-19 Initiated CIBC Sector Outperform
View All

Cronos Group Inc Stock (CRON) Latest News

pulisher
Mar 13, 2025

Cannabis Beverage Market to Witness Massive Growth by 2032 | MedReleaf Corp., Cronos Group Inc - EIN News

Mar 13, 2025
pulisher
Mar 13, 2025

SBI Securities Co. Ltd. Makes New $30,000 Investment in Cronos Group Inc. (NASDAQ:CRON) - Defense World

Mar 13, 2025
pulisher
Mar 11, 2025

Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch

Mar 11, 2025
pulisher
Mar 10, 2025

Cronos Group Inc. to Speak at the 37th Annual Roth Conference - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

CRONCronos Group Latest Stock News & Market Updates - StockTitan

Mar 10, 2025
pulisher
Mar 08, 2025

Private Advisor Group LLC Has $65,000 Position in Cronos Group Inc. (NASDAQ:CRON) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Stock Traders Buy High Volume of Put Options on Cronos Group (NASDAQ:CRON) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Cronos Group Inc to Host Earnings Call - ACCESS Newswire

Mar 06, 2025
pulisher
Mar 06, 2025

Cronos Reports Improved Q4-2024 Financials With Revenues From GrowCo (NASDAQ:CRON) - Seeking Alpha

Mar 06, 2025
pulisher
Mar 06, 2025

Cronos Group's (TSE:CRON) Solid Earnings Are Supported By Other Strong Factors - Yahoo Finance UK

Mar 06, 2025
pulisher
Mar 03, 2025

Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch

Mar 03, 2025
pulisher
Mar 03, 2025

TSX Penny Stocks Spotlight: Cronos Group And 2 Other Noteworthy Picks - Simply Wall St

Mar 03, 2025
pulisher
Mar 03, 2025

Cannabis Beverage Market Growth Probability, Key Vendors and Future Scenario Up To 2032 | Cronos Group Inc - EIN News

Mar 03, 2025
pulisher
Mar 02, 2025

FINAL DEADLINE AND MILLION DOLLAR LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Cronos Group, Inc. Investors to Contact Firm Prior to May 11 Deadline For Class Action Seeking Recovery of Investor Losses; Encourages Investors With L - ACCESS Newswire

Mar 02, 2025
pulisher
Mar 02, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive

Mar 02, 2025
pulisher
Mar 02, 2025

This Week In Cannabis: Big Earnings Reports, Ice Cube's New Brand, Trump's Mixed Signals, Germany's Import Boom And Much More - Benzinga

Mar 02, 2025
pulisher
Mar 02, 2025

Top 10 Cannabis Stocks in a Growing Market (March 2025) - Securities.io

Mar 02, 2025
pulisher
Mar 01, 2025

Cronos Group Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance UK

Mar 01, 2025
pulisher
Mar 01, 2025

Cronos Group Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Mar 01, 2025
pulisher
Mar 01, 2025

Cronos Group (CRON) to Release Earnings on Thursday - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Cronos Group (NASDAQ:CRON) Trading 7.8% HigherStill a Buy? - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Cronos Group (NASDAQ:CRON) Announces Quarterly Earnings Results - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Cronos Group Inc. stock rises Friday, outperforms market - MarketWatch

Feb 28, 2025
pulisher
Feb 28, 2025

MMCAP International Inc. SPC Sells 395,000 Shares of Cronos Group Inc. (NASDAQ:CRON) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Cronos Group’s Growth Hindered by Capacity Constraints and Market Limitations, Maintains Sell Rating - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Cronos Group Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Feb 28, 2025
pulisher
Feb 28, 2025

Cronos Group Reports Strong 2024 Financial Results - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Cronos Group Inc. (NASDAQ:CRON) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Cronos Group Inc (CRON) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

Cronos Group Inc (CRON) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Feb 28, 2025
pulisher
Feb 27, 2025

Cronos: Q4 Earnings Snapshot - New Haven Register

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group Earnings Call Highlights Growth and Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group Inc. stock rises Thursday, outperforms market - MarketWatch

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos reports increase in net revenue in 2024 - StratCann

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability - Benzinga India

Feb 27, 2025
pulisher
Feb 27, 2025

Update: Cronos Group Up 6.6% as It Swings to a Fourth-Quarter Profit and Beats Forecasts - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group (CRON) Q4 2024 Earnings Call Transcript - The Motley Fool

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group reports dramatic turnaround in 2024, ends year with $40M profit - Green Market Report

Feb 27, 2025
pulisher
Feb 27, 2025

Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recap - Benzinga

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group Inc Q4 Earnings Summary - Nasdaq

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group rises after cheery earnings report - Sherwood News

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Cronos Group Q4 2024 sees revenue growth, stock up premarket - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group Achieves Record Growth and Market Leadership in 2024 - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group (CRON) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group Reports 2024 Fourth Quarter and Full-Year Results - The Manila Times

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group Inc. SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Cronos Group (TSE:CRON) Stock Price Down 1.5%Here's What Happened - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Cronos Group Inc. stock falls Wednesday, underperforms market - MarketWatch

Feb 26, 2025
pulisher
Feb 24, 2025

Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025 - The Manila Times

Feb 24, 2025

Cronos Group Inc Stock (CRON) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$10.31
price down icon 0.77%
$33.62
price up icon 0.63%
$99.29
price down icon 1.55%
$8.98
price down icon 2.81%
$108.99
price down icon 0.07%
$131.36
price up icon 0.08%
Cap:     |  Volume (24h):